RESUMO
Gustatory cortex (GC), an assemblage of taste-responsive neurons in insular cortex, is widely regarded as integral to conditioned taste aversion (CTA) retention, a link that has been primarily established using lesion approaches in rats. In contrast to this prevailing view, we found that even the most complete bilateral damage to GC produced by ibotenic acid was insufficient to disrupt postsurgical expression of a presurgical CTA; nor were such lesions sufficient to disrupt postsurgical acquisition and initial expression of a second CTA. However, some rats with lesions were significantly impaired on these tests. Further examination of all conditioned rats with lesions, regardless of the lesion topography, revealed a significant positive association between damage in the posterior portion of GC and especially within adjacent posterior regions of insular cortex. Accordingly, we developed a high-resolution lesion-mapping program that permitted the overlay of the individual lesion maps from rats with CTA impairments to produce a groupwise aggregate lesion map. Comparison of this map with one derived from the unimpaired counterparts indicated a specific lesion "hot spot" associated with CTA deficits that included the most posterior end of GC and overlying granular layer and encompassed an area provisionally referred to in the literature as visceral cortex. Thus, the detailed mapping of the lesion in behaviorally defined subgroups of rats allowed us to exploit the variability in performance to uncloak an important potential component of the functional topography of insular cortex; such an approach could have general applicability to other brain structure-function endeavors as well.
Assuntos
Aprendizagem da Esquiva/fisiologia , Mapeamento Encefálico/métodos , Córtex Cerebral/patologia , Paladar/fisiologia , Animais , Condicionamento Psicológico , Agonistas de Aminoácidos Excitatórios/química , Ácido Ibotênico/química , Processamento de Imagem Assistida por Computador , Masculino , Microscopia , Modelos Neurológicos , Ratos , Ratos Sprague-DawleyRESUMO
In this study, the CZE method for rapid quantitative and qualitative determination of ibotenic acid and muscimol in Amanita mushrooms naturally grown in Poland was developed. The investigations included the species of A. muscaria, A. pantherina, and A. citrina, collected in southern region of Poland. The studied hallucinogenic compounds were effectively extracted with a mixture of methanol and 1 mM sodium phosphate buffer at pH 3 (1:1 v/v) using ultrasound-assisted procedure. The obtained extracts were separated and determined by CZE utilizing a 25 mM sodium phosphate running buffer adjusted to pH 3 with 5% content of acetonitrile v/v. The calibration curves for both analytes were linear in the range of 2.5-7000 µg/mL. The intraday and interday variations of quantitative data were 1.0 and 2.5% RSD, respectively. The recovery values of analyzed compounds were over 87%. The identities of ibotenic acid and muscimol were confirmed by UV spectra, migration time, and measurements after addition of external standard.
Assuntos
Amanita/química , Eletroforese Capilar/métodos , Ácido Ibotênico/análise , Muscimol/análise , Alucinógenos/análise , Alucinógenos/química , Ácido Ibotênico/química , Limite de Detecção , Modelos Lineares , Muscimol/química , Reprodutibilidade dos TestesAssuntos
Ácido Ibotênico/toxicidade , Muscimol/toxicidade , Intoxicação Alimentar por Cogumelos/terapia , Idoso , Amanita/química , Atropina/administração & dosagem , Carvão Vegetal/administração & dosagem , Feminino , Agonistas GABAérgicos , Lavagem Gástrica , Humanos , Ácido Ibotênico/química , Ácido Ibotênico/isolamento & purificação , Japão/epidemiologia , Laxantes/administração & dosagem , Masculino , Pessoa de Meia-Idade , Muscimol/química , Muscimol/isolamento & purificação , Intoxicação Alimentar por Cogumelos/diagnóstico , Intoxicação Alimentar por Cogumelos/epidemiologia , Intoxicação Alimentar por Cogumelos/fisiopatologia , Fisostigmina/administração & dosagem , Receptores de N-Metil-D-Aspartato/agonistas , Receptores de Neurotransmissores/agonistasRESUMO
The constituents of seven mushrooms sold as Amanita muscaria or Amanita pantherina (five A. muscaria and two A. pantherina) and four "extracts purported to contain A. muscaria" products that are currently circulated in Japan were determined. All mushroom samples were identified as A. muscaria or A. pantherina by macroscopic and microscopic observation. The dissociative constituents, ibotenic acid (IBO) and muscimol (MUS), were extracted with 70% methanol twice and determined by gas chromatography/mass spectrometry. The IBO (as the hydrate)/MUS contents were in the range of <10-2845ppm/46-1052ppm in the cap of A. muscaria and 188-269ppm/1554-1880ppm in the cap of A. pantherina. In the caps, these compounds had a tendency to be more concentrated in the flesh than in the cuticle. On the other hand, the IBO/MUS contents in the stem were far lower than in the caps. In the "extracts purported to contain A. muscaria" products, IBO/MUS were detected below the lower limit of calibration curve (<10ppm/<25ppm) or not detected. However, these samples contained other psychoactive compounds, such as psychoactive tryptamines (5-methoxy-N,N-diisopropyltryptamine and 5-methoxy-N,N-dimethyltryptamine), reversible monoamine oxidase inhibitors (harmine and harmaline) and tropane alkaloids (atropine and scopolamine), which were not quantified. This is the first report of the chemical analysis of Amanita mushrooms that are circulated in the drug market.
Assuntos
Amanita/química , Agonistas de Aminoácidos Excitatórios/análise , Agonistas GABAérgicos/análise , Ácido Ibotênico/análise , Muscimol/análise , Atropina/análise , Agonistas de Aminoácidos Excitatórios/química , Toxicologia Forense , Agonistas GABAérgicos/química , Cromatografia Gasosa-Espectrometria de Massas , Harmalina/análise , Harmina/análise , Ácido Ibotênico/química , Japão , Estrutura Molecular , Inibidores da Monoaminoxidase/análise , Antagonistas Muscarínicos/análise , Muscimol/química , Escopolamina/análise , Triptaminas/análiseRESUMO
It is usually believed that drugs of abuse are smuggled into the United States or are clandestinely produced for illicit distribution. Less well known is that many hallucinogens and dissociative agents can be obtained from plants and fungi growing wild or in gardens. Some of these botanical sources can be located throughout the United States; others have a more narrow distribution. This article reviews plants containing N,N-dimethyltryptamine, reversible type A monoamine oxidase inhibitors (MAOI), lysergic acid amide, the anticholinergic drugs atropine and scopolamine, or the diterpene salvinorin-A (Salvia divinorum). Also reviewed are mescaline-containing cacti, psilocybin/psilocin-containing mushrooms, and the Amanita muscaria and Amanita pantherina mushrooms that contain muscimol and ibotenic acid. Dangerous misidentification is most common with the mushrooms, but even a novice forager can quickly learn how to properly identify and prepare for ingestion many of these plants. Moreover, through the ever-expanding dissemination of information via the Internet, this knowledge is being obtained and acted upon by more and more individuals. This general overview includes information on the geographical range, drug content, preparation, intoxication, and the special health risks associated with some of these plants. Information is also offered on the unique issue of when bona fide religions use such plants as sacraments in the United States. In addition to the Native American Church's (NAC) longstanding right to peyote, two religions of Brazilian origin, the Santo Daime and the Uniao do Vegetal (UDV), are seeking legal protection in the United States for their use of sacramental dimethyltryptamine-containing "ayahuasca."
Assuntos
Transtornos Dissociativos/induzido quimicamente , Alucinógenos/efeitos adversos , Alucinógenos/química , Transtornos Dissociativos/psicologia , Fungos/química , Fungos/crescimento & desenvolvimento , Alucinógenos/isolamento & purificação , Ácido Ibotênico/química , Ácido Ibotênico/isolamento & purificação , Ácido Ibotênico/farmacologia , Muscimol/química , Muscimol/isolamento & purificação , Muscimol/farmacologia , N,N-Dimetiltriptamina/química , N,N-Dimetiltriptamina/isolamento & purificação , N,N-Dimetiltriptamina/farmacologia , Desenvolvimento Vegetal , Plantas/química , Plantas/classificação , Estados UnidosRESUMO
4-Alkylated analogues of homoibotenic acid (HIBO) have previously shown high potency and selectivity at ionotropic and metabotropic glutamic acid receptor (iGluR and mGluR) subtypes. Compounds with different selectivity profiles are valuable pharmacological tools for neuropharmacological studies, and the series of 4-alkyl-HIBO analogues have been extended in this paper in the search for versatile agents. Pharmacological characterization of five new analogues, branched and unbranched 4-alkyl-HIBO analogues, have been carried out. The present compounds are all weak antagonists at Group I mGluRs (mGluR1 and 5) presenting only small differences in potencies (Ki values ranging from 89 to 670 microM). Affinities were studied at native and cloned iGluRs, and the compounds described show preference for the AMPA receptor subtypes GluR1 and 2 over GluR3 and 4. However, compared to previous 4-alkyl-HIBO analogues, these compounds show a remarkably high affinity for the Kain preferring subtype GluR5. The observed GluR5 affinities were either similar or higher compared to their GluR1 and 2 affinity. Isopropyl-HIBO showed the highest affinity for GluR5 (Ki=0.16 microM), and represents a unique compound with high affinity towards the three subtypes GluR1, 2 and 5. In general, these compounds represent new selectivity profiles compared to previously reported Glu receptor analogues.
Assuntos
Antagonistas de Aminoácidos Excitatórios/farmacologia , Ácido Ibotênico/análogos & derivados , Receptores de AMPA/antagonistas & inibidores , Receptores de Glutamato Metabotrópico/antagonistas & inibidores , Animais , Linhagem Celular , Relação Dose-Resposta a Droga , Agonistas de Aminoácidos Excitatórios/farmacocinética , Antagonistas de Aminoácidos Excitatórios/química , Antagonistas de Aminoácidos Excitatórios/farmacocinética , Ácido Ibotênico/química , Ácido Ibotênico/farmacocinética , Ácido Ibotênico/farmacologia , Insetos , Ligação Proteica/efeitos dos fármacos , Subunidades Proteicas/metabolismo , Ensaio Radioligante/métodos , Ratos , Receptores de AMPA/fisiologia , Receptores de Glutamato Metabotrópico/fisiologia , Estereoisomerismo , Relação Estrutura-Atividade , Transfecção , Trítio/farmacocinética , Ácido alfa-Amino-3-hidroxi-5-metil-4-isoxazol Propiônico/farmacocinéticaRESUMO
The novel acidic amino acids 6a-c, 7, and 8 have been synthesized via 1,3-dipolar cycloadditions, using nitrile oxides and alkynes. The prepared compounds are heterocyclic analogues of glutamic acid with differing chain lengths. One of these compounds, (RS)-2-amino-3-(3-carboxy-5-methyl-4- isoxazolyl)propionic acid (ACPA, 8), was shown in [3H]AMPA binding studies to be more active than AMPA itself (IC50 = 20 nM compared to IC50 = 79 nM for AMPA). No affinity for NMDA receptors (NMDA-sensitive [3H]glutamic acid binding) was found, and only weak affinity in [3H]kainic acid binding (IC50 = 6.3 microM) was detected. The excitatory activity in rat cortical wedge also showed that ACPA was more potent than AMPA (EC50 = 1.0 microM compared to EC50 = 3.5 microM for AMPA). The depolarizing effect of ACPA could be fully antagonized by the selective non-NMDA antagonist 6-cyano-7-nitro-quinoxazoline-2,3-dione (CNQX), but was unaffected by the selective NMDA antagonist D-2-amino-5-phosphonovaleric acid (AP5).
Assuntos
Aminoácidos/síntese química , Compostos Heterocíclicos/síntese química , Ácido Ibotênico/análogos & derivados , Animais , Encéfalo/metabolismo , Eletrofisiologia , Ácido Ibotênico/química , Ácido Ibotênico/metabolismo , Ratos , Receptores de Aminoácido , Receptores de Superfície Celular/metabolismo , Relação Estrutura-Atividade , Ácido alfa-Amino-3-hidroxi-5-metil-4-isoxazol PropiônicoRESUMO
(S)-Bromohomoibotenic acid [(S)-BrHIbo] stereoselectively antagonized glutamate-stimulated phosphoinositide (PI) hydrolysis in baby hamster kidney (BHK) cells expressing mGluR1a in a competitive manner with an IC50 of 250 microM. However, (S)-BrHIbo did not inhibit (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid [(1S,3R)-ACPD]-induced PI hydrolysis in rat hippocampal slices (S)- or (R)-BrHIbo did not show any effects on forskolin-stimulated cAMP-formation in BHK cells expressing mGluR2 or mGluR4 but did displace [3H]2-amino-4-phosphonobutyrate ([3H]AP4) binding from rat corticalmembranes with high affinities (IC50 = 1.0 microM and 1.1 microM, respectively). These data suggest that (S)-BrHIbo may interest with multiple PI-coupled glutamate receptors, however, at concentrations that are several fold higher than for displacement of [3H]AP4 binding from rat cortical membranes.
Assuntos
Ácido Ibotênico/análogos & derivados , Rim/metabolismo , Receptores de Glutamato Metabotrópico/efeitos dos fármacos , Receptores de Glutamato Metabotrópico/metabolismo , Aminobutiratos/metabolismo , Animais , Ligação Competitiva , Linhagem Celular , Córtex Cerebral/metabolismo , Cricetinae , AMP Cíclico/metabolismo , Cicloleucina/análogos & derivados , Cicloleucina/farmacologia , Relação Dose-Resposta a Droga , Ácido Glutâmico/metabolismo , Ácido Glutâmico/farmacologia , Hipocampo/metabolismo , Hidrólise/efeitos dos fármacos , Ácido Ibotênico/química , Ácido Ibotênico/metabolismo , Ácido Ibotênico/farmacologia , Rim/citologia , Membranas/metabolismo , Fosfatidilinositóis/metabolismo , Quinoxalinas/farmacologia , Receptores de AMPA/antagonistas & inibidores , Receptores de Glutamato Metabotrópico/classificação , EstereoisomerismoRESUMO
We have studied the effects of the enantiomers of 2-amino-3-(3-hydroxyisoxazol-5-yl)propionic acid (homoibotenic acid, HIBO) and analogues substituted with a methyl, bromo or butyl group in the four position of the ring at cloned metabotropic glutamate (mGlu) receptors expressed in Chinese hamster ovary (CHO) cells. In contrast to the parent compound ibotenic acid, which is a potent group I and II agonist, the (S)-forms of homoibotenic acid and its analogues are selective and potent group I antagonists whereas the (R)-forms are inactive both as agonists and antagonists at group I, II, and III mGlu receptors. Interestingly, (S)-homoibotenic acid and the analogues display equal potency at both mGlu1alpha and mGlu5a with Ki values in the range of 97 to 490 microM, (S)-homoibotenic acid and (S)-2-amino-3-(4-butyl-3-hydroxyisoxazol-5-yl)propionic acid [(S)-4-butylhomoibotenic acid] displaying the lowest and highest potency, respectively. The homoibotenic acid analogues thereby differ from mGlu receptor antagonists derived from phenylglycine such as (S)-4-carboxyphenylglycine which only antagonizes mGlu1alpha (Ki = 18 microM) showing no effect at mGlu5a (Ki > 300 microM).
Assuntos
Agonistas de Aminoácidos Excitatórios/farmacologia , Ácido Ibotênico/análogos & derivados , Ácido Ibotênico/farmacologia , Receptores de Glutamato Metabotrópico/agonistas , Animais , Células CHO , Cricetinae , Ácido Ibotênico/química , Ligantes , Receptores de Glutamato Metabotrópico/química , Sistemas do Segundo Mensageiro/efeitos dos fármacos , Estereoisomerismo , Relação Estrutura-AtividadeRESUMO
In this study, we have determined and compared the pharmacological profiles of ibotenic acid and its isothiazole analogue thioibotenic acid at native rat ionotropic glutamate (iGlu) receptors and at recombinant rat metabotropic glutamate (mGlu) receptors expressed in mammalian cell lines. Thioibotenic acid has a distinct pharmacological profile at group III mGlu receptors compared with the closely structurally related ibotenic acid; the former is a potent (low microm) agonist, whereas the latter is inactive. By comparing the conformational energy profiles of ibotenic and thioibotenic acid with the conformations preferred by the ligands upon docking to mGlu1 and models of the other mGlu subtypes, we propose that unlike other subtypes, group III mGlu receptor binding sites require a ligand conformation at an energy level which is prohibitively expensive for ibotenic acid, but not for thioibotenic acid. These studies demonstrate how subtle differences in chemical structures can result in profound differences in pharmacological activity.
Assuntos
Agonistas de Aminoácidos Excitatórios/farmacologia , Ácido Ibotênico/farmacologia , Receptores de Glutamato Metabotrópico/agonistas , Tiazóis/farmacologia , Animais , Células CHO , Cricetinae , Cricetulus , Agonistas de Aminoácidos Excitatórios/química , Ácido Ibotênico/química , Técnicas In Vitro , Ligantes , Masculino , Camundongos , Modelos Moleculares , Conformação Molecular , Ensaio Radioligante , Ratos , Receptores de Glutamato Metabotrópico/classificação , Receptores de Glutamato Metabotrópico/fisiologia , Tiazóis/químicaRESUMO
We describe an improved synthesis and detailed pharmacological characterization of the conformationally restricted analogue of the naturally occurring nonselective glutamate receptor agonist ibotenic acid (RS)-3-hydroxy-4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridine-7-carboxylic acid (7-HPCA, 5) at AMPA receptor subtypes. Compound 5 was shown to be a subtype-discriminating agonist at AMPA receptors with higher binding affinity and functional potency at GluA1/2 compared to GluA3/4, unlike the isomeric analogue (RS)-3-hydroxy-4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridine-5-carboxylic acid (5-HPCA, 4) that binds to all AMPA receptor subtypes with comparable potency. Biostructural X-ray crystallographic studies of 4 and 5 reveal different binding modes of (R)-4 and (S)-5 in the GluA2 agonist binding domain. WaterMap analysis of the GluA2 and GluA4 binding pockets with (R)-4 and (S)-5 suggests that the energy of hydration sites is ligand dependent, which may explain the observed selectivity.
Assuntos
Antagonistas de Aminoácidos Excitatórios/farmacologia , Ácido Ibotênico/farmacologia , Receptores de Glutamato/efeitos dos fármacos , Animais , Linhagem Celular , Cristalografia por Raios X , Antagonistas de Aminoácidos Excitatórios/química , Ácido Ibotênico/química , Modelos Moleculares , Ratos , Spodoptera , Xenopus laevisRESUMO
Two alternative "ring switch" based syntheses have been shown to give access to the reduced protected homochiral analogues, 27, 28 and 36, of the CNS active compound ibotenic acid.
Assuntos
Ácido Ibotênico/análogos & derivados , Ácido Ibotênico/síntese química , Ácido Pirrolidonocarboxílico/química , Agonistas de Aminoácidos Excitatórios/síntese química , Agonistas de Aminoácidos Excitatórios/química , Ácido Ibotênico/química , Estrutura Molecular , OxirreduçãoRESUMO
A complementary DNA encoding the rat NMDA receptor has been cloned and characterized. The single protein encoded by the cDNA forms a receptor-channel complex that has electrophysiological and pharmacological properties characteristic of the NMDA receptor. This protein has a significant sequence similarity to the AMPA/kainate receptors and contains four putative transmembrane segments following a large extracellular domain. The NMDA receptor messenger RNA is expressed in neuronal cells throughout the brain regions, particularly in the hippocampus, cerebral cortex and cerebellum.
Assuntos
Encéfalo/metabolismo , Receptores de N-Metil-D-Aspartato/genética , Sequência de Aminoácidos , Animais , Sequência de Bases , Clonagem Molecular , Eletrofisiologia , Ácido Ibotênico/análogos & derivados , Ácido Ibotênico/química , Ácido Caínico/química , Dados de Sequência Molecular , Estrutura Molecular , RNA Mensageiro/análise , Ratos , Xenopus/genética , Ácido alfa-Amino-3-hidroxi-5-metil-4-isoxazol PropiônicoRESUMO
A method for measuring [3H]-AMPA binding in rat cortex membranes is described. Specific binding was saturable and accounted for 95% of total binding at 5 nM of [3H]-AMPA. Non linear curve fitting of [3H]-AMPA saturation isotherms suggested the presence of two binding sites: the high affinity site showed a pKd of 8.26 +/- 0.07 (Kd = 5.49 nM) and a Bmax of 0.19 +/- 0.03 pmol/mg protein, whereas the low affinity site indicated a pKd of 7.28 +/- 0.05 (Kd = 52 nM) and a Bmax of 1.30 +/- 0.23 pmol/mg protein. The pharmacological profile of [3H]-AMPA binding has been determined by studying a series of compounds in binding displacement experiments: Quisqualate was the most potent inhibitor of [3H]-AMPA binding (IC50 = 9.7 nM), followed by AMPA (19 nM), CNQX, DNQX and L-Glutamate (272-373 nM). Kainate was a moderate displacer (6.2 microM); Ibotenic acid and glycine were very weak inhibitors (74 and 92 microM, respectively). CPP, GAMS and L-Aspartic acid showed IC50-values of over 400 microM and MK-801, DL-AP5 and NMDA were almost inactive at the maximal concentration used in our experiments.
Assuntos
Córtex Cerebral/química , Ácido Ibotênico/análogos & derivados , Receptores de Neurotransmissores/química , Membranas Sinápticas/química , Animais , Ácido Ibotênico/química , Masculino , Ensaio Radioligante/métodos , Ratos , Ratos Endogâmicos , Receptores de AMPA , Trítio , Ácido alfa-Amino-3-hidroxi-5-metil-4-isoxazol PropiônicoRESUMO
Glutamate receptors belonging to the subclass specifically activated by alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) were solubilized from rat forebrain membranes with Triton X-100 and partially purified through a series of three chromatographic steps. Specific [3H]AMPA binding increased 30-60-fold during the isolation procedure. A protein band recognized by antibodies against specific amino acid sequences of the glutamate receptor-A subunit was enriched with each purification step; the molecular mass of this band (105 kDa) corresponded to that of cloned AMPA receptor subunits. Photoaffinity labeling of forebrain membranes with 6-cyano-7-[3H]nitroquinoxaline-2,3-dione, a specific antagonist of the AMPA receptor, labeled a single band that comigrated with the immunolabeled protein. On reconstitution of the partially purified material into bilayer patches, single-channel current fluctuations were elicited by 300 nM AMPA and blocked by 1 microM 6,7-dinitroquinoxaline-2,3-dione.
Assuntos
Ácido Ibotênico/análogos & derivados , Receptores de Neurotransmissores/isolamento & purificação , Receptores de Neurotransmissores/fisiologia , Animais , Ácido Ibotênico/química , Ácido Ibotênico/metabolismo , Bicamadas Lipídicas/química , Prosencéfalo/química , Prosencéfalo/metabolismo , Ligação Proteica , Ratos , Receptores de AMPA , Receptores de Neurotransmissores/química , Ácido alfa-Amino-3-hidroxi-5-metil-4-isoxazol PropiônicoRESUMO
The (R)- and (S)-forms of 2-amino-3-(3-hydroxyisoxazol-5-yl)propionic acid (homoibotenic acid, HIBO) were synthesized, using (S)-BOC-phenylalanine as a chiral auxiliary and their absolute stereochemistry correlated with that of (R)-Br-HIBO. The enantiomeric excesses for (R)-HIBO (1) (> 99.5%) and (S)-HIBO (2) (99.5%) were determined using chiral HPLC. Whereas compounds 1 and 2 were equipotent inhibitors of the binding of [3H]glutamic acid in the presence of calcium chloride, 2 showed AMPA agonist activity and 1 very weak NMDA agonist activity.